~~<i id='DD87E43672'><strike id='DD87E43672'><tt id='DD87E43672'><pre id='DD87E43672'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：fashion 2025-09-30 13:21:44 Page View：1263

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The CDC's new social media misinformation war
Next article： The cancer drug shortage isn’t new — and neither are the solutions

explore

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

340B reform proposal comes out of Senate working group

Sen.JohnThuneisoneofagroupoflawmakersthatisworkingon340Breformlegislation.BRENDANSMIALOWSKI/AFPviaGe

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Problems with a popular proposal to regulate AI in health care

AdobeAsleadersacrossfederalagenciesswiftlyadvanceregulationsforAIinhealthcare,oneproposalnowseemstoo